AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04476420 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Betamethasone Valerate
Description: it is a conventionally used drug for treating OSMF
Study NCT05705492 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Administration
Description: Given PO
Study NCT04249219 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Viewing e-cigarette ads
Description: All participants will see the same e-cigarette ads presented in a random order.
Study NCT04976595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Natesto
Description: Nasal gel containing testosterone 11 mg/dose (5.5 mg/nostril) three times daily.
Study NCT05712161 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DurAVRTM THV System
Description: The DurAVR™ Transcatheter Heart Valve (THV) is a balloon expandable transcatheter aortic valve
Study NCT06286514 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: This is an observational study
Study NCT05763082 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: roflumilast cream 0.3%
Description: test product
Study NCT05763082 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zoryve
Description: Reference Listed Drug product
Study NCT05763082 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study NCT05367609 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Preoperative Genotyping
Description: Genotype based risk prediction and personalized pain management
Study NCT00098163 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ALVAC-HIV vCP1521
Description: One 1-ml dose of HIV-1 vaccine administered after birth on or before Day 3 and at weeks 4, 8, and 12.
Study NCT00098163 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: ALVAC HIV-1 vCP1521
Description: One 1-ml dose of HIV-1 vaccine placebo administered after birth on or before Day 3 and at Weeks 4, 8, and 12.
Study NCT05531019 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Echinochrome A
Description: Dietary Supplement with Echinochroma A Simple randomized design, in this arm patients will take 6ml of a 0.025% Echinochroma A solution twice a day for 90 days. 3 mg of Echinochroma A will be consumed per day.
Study NCT05531019 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Simple randomized design, in this arm patients will take 6ml of an fructose aqueous solution twice a day for 90 days with the same flavor as the treatment
Study NCT05705492 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04780724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hypoxic gas mixture
Description: Gas mixture of 12% O2 and 88% N2 for five minutes.
Study NCT04780724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hypercapnic and hypoxic gas mixture
Description: Gas mixture of 12% O2, 5% CO2, and 88% N2 for five minutes.
Study NCT04780724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SpO2 measurement
Description: Two SpO2 measuring devices are active simultaneously during measurement.
Study NCT05705492 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04990206 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TranS-C
Description: TranS-C will be provided in eight weekly, one-on-one 50-minute sessions delivered remotely by two-way video conferencing. Each week will include goal setting and homework assignments which will be reviewed in the following session.~The sessions will include information on sleep and circadian rhythms, behavioral change and motivation, and goal setting. The topics covered in the sessions include establishing regular sleep-wake times, learning a wind-down route, learning a wake-up routine, improving daytime functioning, correcting unhelpful sleep-related beliefs, and maintenance of behavior change.
Study NCT05399095 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supine positioning: 5 days
Description: Supine positioning for 5 days after DMEK
Study NCT05399095 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supine positioning: 1 days
Description: Supine positioning for 1 days after DMEK
Study NCT06400680 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spine Kinematic Assessment with Optoelectronic system
Description: All measurements will be obtained using an optoelectronic multicamera system for human motion analysis (with eight high-resolution cameras with infrared light and a sampling frequency of 100 Hz.~The experimental protocol require the positioning of markers (plastic spheres covered by reflecting film). Markers will be placed by clinical operators (physiotherapists with training in optoelectronic system for human motion analysis) after training and experience in recognition of the position of spinous and transversal processes, by manual identification.~During the data acquisition protocol, the subject perform five trial of walking barefoot on a 6 m distance at a self-selected normal-pace speed.~Every subject repeated this operations 2 times with 2 different operators.
Study NCT05059912 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Humanized CD7 CAR-T cells
Description: Patients will receive infusion of CAR T-cells targeting CD7 to confirm the safety and efficacy of CD7 CAR T-Cells in CD7+ relapsed or refractory T cell lymphoma
Study NCT04780698 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 RT-PCR Assay for Detection of COVID-19 Infection
Description: COVID-19 infection and antibody testing
Study NCT05425849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: rose oil aromatherapy
Description: Aromatherapy refers to the medicinal or therapeutic use of essential oils absorbed through the skin or the olfactory system. The positive effects of social support, such as hand-holding, on anxiety and pain have been described
Study NCT05290909 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The protocol of blended and problem-based learning
Description: The protocol of blended and problem-based learnin: The online platforms used in this research are the school's iLMS platform, online digital learning, and online opinion exchange platform. It will use online resources (Google, open educational resources, YouTube copyrighted medical micro-movies, and audio-visual materials), and the theme will be elderly care or emerging Multimedia resources on infectious themes, as well as real-time interaction with kahoot or Slido electronic whiteboards, will be uploaded to the office3655The One website. Drive is provided by the school (the school account is used to store course resources) and the system of digital theoretical course concepts in advance. Broadcasting, video (such as: values and conflicts; ethics and morality; patient rights and responsibilities; nurses' rights and responsibilities; ethical theory; basic ethical principles; ethical dilemmas and ethical decision-making; etc.), pre-recorded and stored on the Internet Road platform iLMS.
Study NCT05290909 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The traditional problem-oriented teaching model
Description: The traditional problem-oriented teaching model: There will be two PBL case introductions throughout the semester, with face-to-face teaching in physical classrooms.
Study NCT06281210 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Omission of surgical treatment
Description: Omission of surgery in patients with pCR after neoadjuvant chemotherapy and negative VABB biopsy
Study NCT05174949 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (high-definition)
Description: Three conditions (2 mA, 20 mins):~1. anodal stimulation over the ipsilesional primary motor cortex~2. cathodal one over the contralesional premotor cortex~3. Sham
Study NCT05788276 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin 10mg Tab
Description: Dapagliflozin active tablets
Study NCT05788276 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo tablets
Study NCT04017390 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Theraworx Foam
Description: Apply Theraworx Foam alone
Study NCT04017390 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Foam
Description: Apply placebo foam alone
Study NCT04017390 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Theraworx Foam and night splint
Description: Apply Theraworx Foam and night time splint
Study NCT04017390 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Placebo Foam and night time splint
Description: Apply placebo foam and night time splint
Study NCT06207643 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: carotid endarterectomy
Description: removing carotid artery atheromatous plaque surgically
Study NCT05434299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TFX05-01
Description: TFX05-01 for intravenous
Study NCT05157516 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: erector spinea block
Description: the patients will receive a single injection erector spinea block after induction of general anesthesia
Study NCT05157516 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Caudal epidural block
Description: the patients will receive caudal epidural block after induction of general anesthesia
Study NCT05015764 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fluid Management
Description: Removal of excess extracellular fluid using diuretics
Study NCT05015764 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Reprieve Cardiovascular System
Description: System with Fluid Management Module
Study NCT04844918 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: Administered SC
Study NCT04844918 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC
Study NCT05185518 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of novel insulin injection port
Description: use subcutaneous port into which glucose monitor is embedded
Study NCT06031597 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: Radiotherapy techniques: Volumetric-modulated arc therapy (VMAT) and image guided radiotherapy (IGRT).~Radiotherapy dose: Radical prescription dose of 60 gray (Gy) ± 10%, 2 Gy per session, once a day, 5 days a week.
Study NCT06031597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platinum-Based Drug
Description: Cisplatin 25 mg/m2 once per week for a total of 5-6 cycles. For participants who have not completed 4 cycles of conversion chemotherapy in combination with immunotherapy, the original chemotherapy regimen may also be used, with the total number of chemotherapy cycles not exceeding 6 cycles.
Study NCT06031597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Immunotherapy
Description: Concurrent programmed cell death 1 (PD-1) or programmed cell death L1 (PD-L1) inhibitors every 3 weeks during radiotherapy and no more than 3 doses during the course of radiotherapy.
Study NCT06031597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Immunotherapeutic Agent
Description: All participants will be evaluated within 1-42 days after receiving radiation (chemotherapy). If disease progression does not occur, adjuvant therapy with a PD-1 or PD-L1 inhibitor is continued until disease progression up to 1 year.
Study NCT06522945 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TQD3524
Description: Polymyxin antibiotics
Study NCT05761210 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sample collection
Description: Blood sample collection
Study NCT05120466 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AD IT UP media literacy intervention
Description: AD IT UP was originally developed in 2006 as a classroom-based cigarette prevention program focused on traditional media influences, and was converted to a web-based program in 2011. In 2019, the AD IT UP program was updated substantially to include other forms of tobacco, such as e-cigarettes, and other forms of media, such as social media.
Study NCT05120466 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual health education curriculum
Description: The school's regular health education curriculum includes classroom lectures, hands on activities and group work.
Study NCT05120466 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Usual health education curriculum
Description: The school's regular health education curriculum includes classroom lectures, hands on activities and group work.
Study NCT05477706 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalized Support for Progress (PSP)
Description: Personalized Support for Progress (PSP) is a Peer Specialist delivered intervention in which a peer supports Veterans in prioritizing their needs and attaining access to the Veterans' preferred services.
Study NCT05477706 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tailored Referral (TR)
Description: TR consists of detailed resource information and referral, consistent with standard practice.
Study NCT06489691 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 6-minute walk test (6MWT)
Description: 6-minute walk test (6MWT) will be performed according to clinical standards
Study NCT06128174 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Farawave PFA catheter
Description: The FARAWAVE Pulsed Field Ablation Catheter (FARAWAVE Catheter) is a flexible tube with electrodes at the end, which is inserted through a blood vessel in your groin. The study doctor will use the FARAWAVE Catheter to deliver the pulsed electrical energy to ablate (destroy) the heart tissue. This process is designed to create a scar in the heart tissue, stopping the unwanted electrical signals that cause the atrial fibrillation.
Study NCT05514574 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music
Description: hussoni duseni  music
Study NCT05514574 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stress ball
Description: Stress ball squeeze
Study NCT05033080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-121/TEZ/D-IVA
Description: Fixed-dose combination tablets for oral administration.
Study NCT05033080 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ELX/TEZ/IVA
Description: Fixed-dose combination tablets for oral administration.
Study NCT05033080 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IVA
Description: Tablet for oral administration.
Study NCT05033080 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo (matched to VX-121/TEZ/D-IVA)
Description: Placebo matched to VX-121/TEZ/D-IVA for oral administration.
Study NCT05033080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (matched to ELX/TEZ/IVA)
Description: Placebo matched to ELX/TEZ/IVA for oral administration.
Study NCT05033080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (matched to IVA)
Description: Placebo matched to IVA for oral administration.
Study NCT04801745 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Healthy vegan diet
Description: Participants will attend group lessons and individual nutrition counseling to help them adopt a healthy vegan diet.
Study NCT04801745 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: My Plate - Low Purine
Description: Participants will attend group lessons and individual nutrition counseling to help them adopt a balanced diet in accordance with my plate, and emphasis on choosing low purine options from the protein food groups.
Study NCT04801745 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: My Plate - Low Purine
Description: Participants will attend group lessons and individual nutrition counseling to help them adopt a balanced diet in accordance with my plate, and emphasis on choosing low purine options from the protein food groups.
Study NCT04801745 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Amla fruits
Description: Participants will be provided with powdered amla fruits, and will be instructed to take 3g per day.
Study NCT05408143 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CC
Description: To promote prompt effective care for medically complex children at all hours, we developed an outpatient comprehensive care (CC) program at the University of Texas Health Science Center at Houston (UTH) that now includes a hospital consultation service by the outpatient CC providers (the hospital component) and a conventional telemedicine (CTM) audio-visual program (the home component).
Study NCT05408143 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CC
Description: To promote prompt effective care for medically complex children at all hours, we developed an outpatient comprehensive care (CC) program at the University of Texas Health Science Center at Houston (UTH) that now includes a hospital consultation service by the outpatient CC providers (the hospital component) and a conventional telemedicine (CTM) audio-visual program (the home component).
Study NCT05408143 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: enhanced telemedicine (ETM)
Description: An enhanced telemedicine program (using HIPAA-compliant, mobile TytoCareTM devices) will be added to CC to allow providers to remotely visualize the skin, throat, \& ears, auscultate the heart \& lungs, and measure illnesses during clinic hours and chronic illnesses during the detailed patient evaluation to be conducted at least every 6 months by virtual patient rounds in the home. These visits will involve the parent(s), the PCP, and if needed any of 10 specialists, particularly pulmonology, gastroenterology, neurology, and physical medicine and rehabilitation. A social worker, nutritionist, or psychologist will be involved as needed. Each PCP will perform 2-3 virtual patient rounds per week to proactively identify medical problems, suboptimal adherence to treatment, dosing errors, or other problems and intervene before CMC develop a serious illness or require avoidable clinic visits, Emergency Department visits, or hospitalizations.
Study NCT06448455 — intervention group
Intervention type: OTHER
Intervention: Observation
Description: Collect relevant data of patients
Study NCT05236621 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: 4 mg pomalidomide capsules administered orally
Study NCT05236621 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 40 mg dexamethasone tablets administered orally
Study NCT06039371 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy
Description: Undergo a biopsy
Study NCT06039371 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo a biopsy
Study NCT06039371 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06039371 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06039371 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Scan
Description: Undergo bone scan
Study NCT06039371 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan
Study NCT06039371 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Given IV
Study NCT06039371 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV
Study NCT06039371 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT
Study NCT06039371 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT06039371 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Etoposide
Description: Given PO
Study NCT06039371 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given PO
Study NCT06039371 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT06039371 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT06039371 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06039371 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06039371 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Testosterone Cypionate
Description: Given IM
Study NCT06039371 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone Cypionate
Description: Given IM
Study NCT06473454 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aerobic exercise and basic body awareness therapy ( exercise)
Description: exercise
Study NCT04522973 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Beverage with ethanol and E-cigarette liquid with ethanol
Description: Beverage with ethanol and E-cigarette liquid with ethanol